Clinical trial

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

NCT04145375

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2019-11-12

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2019-11-12Date precision: day

Registry last updated2026-05-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

mCRPCunresolved

Interventions

ZEN003694DRUG

EnzalutamideDRUG · verified · RxNorm: enzalutamide

Sponsors & collaborators

Zenith Epigeneticslead sponsor

Mapped research locations

San FranciscoCalifornia, United States1 PortlandOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04145375 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.